Terns Pharmaceuticals, Inc. (TERN)

NASDAQ: TERN · IEX Real-Time Price · USD

8.49

-0.21 (-2.36%)

At close: Jul 19, 2024, 4:00 PM

8.55

+0.07 (0.77%)

Pre-market: Jul 22, 2024, 7:05 AM EDT

Terns Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	0	0	0	1	0	0	Upgrade
Gross Profit	0	0	0	1	0	0	Upgrade
Selling, General & Admin	38.82	39.06	22.41	19.55	9	8.66	Upgrade
Research & Development	65.03	63.5	39.62	31.31	28.03	61.53	Upgrade
Operating Expenses	103.85	102.56	62.03	50.86	37.03	70.2	Upgrade
Operating Income	-103.85	-102.56	-62.03	-49.86	-37.03	-70.2	Upgrade
Other Expense / Income	-13.07	-12.59	-2.04	-0.21	2.22	-1.57	Upgrade
Pretax Income	-90.78	-89.97	-59.99	-49.65	-39.24	-68.63	Upgrade
Income Tax	0.28	0.24	0.36	0.51	0.81	-0.02	Upgrade
Net Income	-91.06	-90.21	-60.35	-50.16	-40.05	-68.61	Upgrade
Preferred Dividends	0	0	0	0	-10.7	0	Upgrade
Net Income Common	-91.06	-90.21	-60.35	-50.16	-29.35	-68.61	Upgrade
Shares Outstanding (Basic)	74	71	36	23	0	0	Upgrade
Shares Outstanding (Diluted)	74	71	36	23	0	0	Upgrade
Shares Change	6.62%	97.76%	58.69%	7862.47%	55.60%	145.81%	Upgrade
EPS (Basic)	-1.26	-1.27	-1.67	-2.21	-102.93	-374.39	Upgrade
EPS (Diluted)	-1.26	-1.27	-1.67	-2.21	-102.93	-374.39	Upgrade
Free Cash Flow	-75.89	-67.44	-49.38	-42.17	-30.39	-67.12	Upgrade
Free Cash Flow Per Share	-1.02	-0.95	-1.37	-1.86	-106.58	-366.26	Upgrade
Gross Margin	-	-	-	100.00%	-	-	Upgrade
Operating Margin	-	-	-	-4986.00%	-	-	Upgrade
Profit Margin	-	-	-	-5015.80%	-	-	Upgrade
Free Cash Flow Margin	-	-	-	-4216.70%	-	-	Upgrade
EBITDA	-89.88	-89.09	-58.96	-49.14	-38.85	-68.44	Upgrade
EBITDA Margin	-	-	-	-4913.80%	-	-	Upgrade
Depreciation & Amortization	0.9	0.88	1.03	0.51	0.39	0.2	Upgrade
EBIT	-90.78	-89.97	-59.99	-49.65	-39.24	-68.63	Upgrade
EBIT Margin	-	-	-	-4965.00%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).